BioMarin Pharmaceutical Inc. (0HNC.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 11.38B |
| Enterprise Value | 10.71B |
| P/E Ratio | 175.53 |
| PEG Ratio | -1.97 |
| Price/Sales Ratio | 3.78 |
| Price/Book Ratio | 2.04 |
| Enterprise/Revenue | 4.76 |
| Enterprise/EBITDA | 42.05 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.08 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.01 |
Income Statement
| Revenue | 3.22B |
| Revenue/Share | 17.65 |
| Gross Profit | 2.48B |
| EBITDA | 613.03M |
| Net Income | 348.9M |
| Diluted EPS | 1.8 |
Balance Sheet
| Total Cash | 874.01M |
| Total Cash/Share | 4.53 |
| Total Debt | 4.22B |
| Total Debt/Equity | 0.66 |
| Current Ratio | 2.39 |
| Book Value Per Share | 32.76 |
Price History
| 52-Week Change | 14.61 |
| 52-Week High | 99.65 |
| 52-Week Low | 66.64 |
| Moving Average 50 Days | 90.32 |
| Moving Average 200 Days | 89.61 |
Statistics
| Average Volume | 5,967 |
| Shares Outstanding | 178.06M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
